Scientific Advisory Board (SAB)
The Scientific Advisory Board (SAB) serves as an external consultant to the Diabetes Research Institute, evaluating research programs and progress, as well as providing guidance and assistance in administrative policies and issues. The members of the SAB are appointed by the Dean of the University of Miami Miller School of Medicine and the University’s Vice President and Provost.
The SAB meets with DRI faculty on a regular basis and presents a written report to the Dean of the School of Medicine. The DRI’s Scientific Advisory Board is comprised of several distinguished scientists who have earned international recognition for their contributions to diabetes research.
F. Charles Brunicardi, M.D., F.A.C.S.
Chair, Department of Surgery
University of Toledo College of Medicine, Toledo, OH
Christopher B. Newgard, Ph.D.
Director, Sarah Stedman Center for Nutritional Studies
W. David and Sarah W. Stedman Distinguished Professor
Department of Pharmacology and Cancer Biology
Duke University Medical Center
James Shapiro, M.D., Ph.D., FRCSC
Director, Clinical Islet Transplant Program
Canadian Research Chair in Transplantation (CIHR/Wyeth)
University of Alberta
Megan Sykes, M.D.
Michael J. Friedlander Professor of Medicine
Professor of Microbiology & Immunology and Surgical Services
Columbia Center for Translational Immunology (CCTI)
Columbia University Medical Center
Massimo Trucco, M.D.
Professor of Pediatrics, Pathology, Human Genetics and Epidemiology
University of Pittsburgh
Hillman Professor of Pediatric Immunology
Head, Division of Immunogenetics
Children's Hospital of Pittsburgh
Kathryn Wood, M.D.
Professor of Immunology
Nuffield Department of Surgery
University of Oxford
John Radcliffe Hospital
Oxford, U.K.